IPHA Innate Pharma S.A.
$1.91
Innate Pharma S.A. (IPHA) SEC Filings
Everything IPHA has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.
| Date | Form | Filing |
|---|---|---|
| 6-K Capital Raise · Earnings Release · Executive Change · Guidance Update · Material Agreement | View filing | |
| 6-K Capital Raise · Earnings Release · Material Agreement · Restructuring | View filing | |
| 6-K Material Agreement | View filing | |
| 6-K Earnings Date Announcement | View filing | |
| 6-K Investor Presentation | View filing | |
| 6-K Capital Raise · Guidance Update | View filing |
Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.